Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
18.54
+0.75 (4.22%)
Apr 28, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Other Segment
140.82M
56.78M24.59M45.81M48.32M
Other Segment Growth
-
130.96%-46.33%-5.19%-9.36%
Medicine
1.80B
2.61B2.02B1.81B1.91B
Medicine Growth
-
29.26%11.32%-4.89%-32.51%
Group Investment Division
1.65M
----
Food
199.70M
363.28M359.32M155.58M140.75M
Food Growth
-
1.10%130.95%10.54%9.95%
Offset of Business Segment
-188.42M
----
Chain drugstore wholesale and retail
383.29M
375.02M448.39M248.49M141.50M
Chain drugstore wholesale and retail Growth
-
-16.36%80.45%75.61%85.76%
Unallocated Other Operating Income
-
45.58M17.95M41.05M15.11M
Unallocated Other Operating Income Growth
-
153.85%-56.27%171.69%116.32%
Total
2.34B
3.45B2.87B2.30B2.25B
Total Growth
-
20.25%24.50%2.31%-27.09%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
North East China
843.00M
1.14B1.08B704.81M-
North East China Growth
-
5.01%53.49%--
North China
205.79M
270.10M242.04M217.61M-
North China Growth
-
11.59%11.23%--
East China
526.55M
978.65M682.98M602.64M-
East China Growth
-
43.29%13.33%--
South China
298.52M
414.79M363.68M319.41M-
South China Growth
-
14.05%13.86%--
Northwest China
150.16M
235.88M197.79M162.96M-
Northwest China Growth
-
19.26%21.37%--
Southwest China
311.17M
413.75M299.81M296.35M-
Southwest China Growth
-
38.01%1.17%--
Foreign
-
-117.23K--
China
-
---2.25B
China Growth
-
----27.09%
Total
2.34B
3.45B2.87B2.30B2.25B
Total Growth
-
20.25%24.50%2.31%-27.09%
Source: S&P Global Market Intelligence.